Edwards Lifesciences Corporation Operating Lease Cost
Edwards Lifesciences Corporation (EW) reported Operating Lease Cost of $29.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-25
- Edwards Lifesciences Corporation operating lease, cost for the quarter ending 2019-12-31 was $7.20M.
- Edwards Lifesciences Corporation operating lease, cost for the quarter ending 2019-09-30 was $7.20M.
- Edwards Lifesciences Corporation operating lease, cost for the quarter ending 2019-06-30 was $7.20M.
- Edwards Lifesciences Corporation operating lease, cost for the quarter ending 2019-03-31 was $6.30M.
- Edwards Lifesciences Corporation operating lease, cost for fiscal 2025 was $29.30M, a 4.27% increase from fiscal 2024.
- Edwards Lifesciences Corporation operating lease, cost for fiscal 2024 was $28.10M, a 4.46% increase from fiscal 2023.
- Edwards Lifesciences Corporation operating lease, cost for fiscal 2023 was $26.90M, a 5.08% increase from fiscal 2022.
- Edwards Lifesciences Corporation operating lease, cost for fiscal 2022 was $25.60M, a 13.80% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $29.30M 10-K · filed 2026-02-25 | ||||
| 2024-12-31 | $28.10M 10-K · filed 2026-02-25 | ||||
| 2023-12-31 | $26.90M 10-K · filed 2026-02-25 | $30.10M 10-K · filed 2024-02-12 | |||
| 2022-12-31 | $25.60M 10-K · filed 2025-02-28 | $28.80M 10-K · filed 2023-02-13 | |||
| 2021-12-31 | $29.70M 10-K · filed 2024-02-12 | ||||
| 2020-12-31 | $30.50M 10-K · filed 2023-02-13 | ||||
| 2019-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $14.40M derived: sum of 2 quarters · filed 2022-02-14 | $21.60M derived: sum of 3 quarters · filed 2022-02-14 | $27.90M 10-K · filed 2022-02-14 | |
| 2019-09-30 | $7.20M 10-Q · filed 2019-10-25 | $14.40M derived: sum of 2 quarters · filed 2019-10-25 | $20.70M 10-Q · filed 2019-10-25 | ||
| 2019-06-30 | $7.20M 10-Q · filed 2019-07-26 | $13.50M 10-Q · filed 2019-07-26 | |||
| 2019-03-31 | $6.30M 10-Q · filed 2019-04-26 | ||||
| 2018-12-31 | $27.00M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |